Capsule Endoscopes Market: Increasing Prevalence of Gastrointestinal Disorders to Drive Market Growth to US$ 1,398.63 Million by 2031

As per the latest market research by Business Market Insights (BMI), the research report " Capsule Endoscopes Market Size and Forecast (2025–2031)" forecasts how the market is set to surge 7.81% by 2031. The global capsule endoscopes market is expanding with advances in imaging, AI integration, and wireless technology that enhance diagnostic accuracy. Rising cases of gastrointestinal disorders and preference for non-invasive, sedation-free procedures are key drivers. Growing adoption of single-use and remote monitoring capsules further supports infection control and healthcare efficiency worldwide.

The report forecasts the market to expand from US$ 826.45 million in 2024 to US$ 1,398.63 million by 2031, registering a robust CAGR of 7.81% over the 2025–2031 period.

The market for capsule endoscopes around the world is experiencing stable growth as both hospitals and clinics are increasingly utilizing this non-invasive method. Capsule endoscopes enable physicians to visualize the small intestine, the colon, and the esophagus without having to perform surgery, thereby making it a more pleasant experience for the patient. Improvements in imaging, battery life, and wireless data transfer functionality ensure that these capsules are more precise and efficacious than their predecessors. The introduction of AI-assisted analysis also allows for the fast identification of gastrointestinal abnormalities, which improves the diagnosis and treatment of gastrointestinal diseases. The market is driven by emerging cases of gastrointestinal diseases and the rising demand for early detection in a traditional clinical environment. The increased prevalence of single-use, disposable capsules offers enhanced infection control, while remote monitoring and outpatient care applications improve overall efficiency in today's healthcare systems. In conclusion, as technology and adoption improve, the market is actively growing worldwide.

Overview of report findings

Market Growth

The capsule endoscopes market is projected to grow from US$ 826.45 million in 2024 to US$ 1,398.63 million by 2031, registering a compound annual growth rate (CAGR) of 7.81% between 2025 and 2031.

The capsule endoscopes market is driven by the increasing prevalence of gastrointestinal disorders, colorectal cancer, and other related conditions. Rising preference for minimally invasive, non-surgical diagnostic procedures is boosting adoption. Growth is further supported by expanding use in outpatient and ambulatory care settings, increasing healthcare infrastructure, and rising awareness of early disease detection.

Increasing Prevalence of Gastrointestinal Disorders

One key factor contributing to the growth of the capsule endoscopes market is the increasing prevalence of gastrointestinal (GI) disorders such as inflammatory bowel disease (IBD), obscure GI bleeding, and the growing need for screening for colorectal cancer - all of which require accurate, expedient and thorough examination of one’s gastrointestinal tract. These GI disorders are often diagnosed through traditional endoscopy that can be invasive and uncomfortable, while patients often do not tolerate being examined deeply within the small intestine. Capsule endoscopy serves as a non-invasive, patient-friendly option that allows for obtaining high-resolution images of the entire GI tract. The non-invasive nature of capsule endoscopic examination allow clinicians to detect lesions, polyps, bleeding sites and other possible abnormalities quickly and provide the opportunity for early intervention for improved outcomes. As global incidence of GI disorders, particularly IBD and colorectal cancer continue to rise, global healthcare providers are adopting capsule endoscopes, leading to a growing market presence in the diagnosis and improved patient outcomes.

Patient preference for minimally invasive procedures

The rising patient demand for minimally invasive, sedation-free procedures is one of the primary contributing factors to the capsule endoscopes market. Traditional endoscopy can be uncomfortable to patients, almost always requiring sedation, often leading to anxiety and sometimes, longer times for recovery. Conversely, capsule endoscopy involves a patient swallowing a small, pill-sized device that takes high-quality images of your gastrointestinal tract while transferring only a minor level of comfort—without the need for sedation. This reduces hospital stay and procedure-related stress, thereby increasing the appeal of capsule endoscopy compared to traditional endoscopy. The combination of comfort and convenience associated with capsule endoscopy enhances the willingness of patients to undergo routine screening of gastrointestinal disorders, including early detection. Patient awareness and growing demand for less invasive options leads healthcare thought leaders to adopt capsule endoscopes more often at healthcare facilities all over the world—further expanding the capsule endoscopes market.

Geographic Insights

North America accounts for the largest share in the global capsule endoscopes market, aided by a sophisticated healthcare infrastructure, widespread adoption of minimally invasive procedures, and access to trained medical personnel. Strong reimbursement policies, increased demand for early detection of diseases, and well-developed gastroenterology programs are driving the market. High uptake of high-definition imaging, AI-based analysis, and wireless capsule systems further enhances growth. Ambulatory and outpatient facilities increasingly adopt portable, disposable capsules, optimizing efficiency and infection control.

Europe is the second most dominant region, with nations such as Germany, France, and the UK recording high levels of adoption of minimally invasive diagnostics. Investments in healthcare, advanced hospital networks, good collaborations with manufacturers of devices, and patient safety and sterilization technology promote growth.

Asia Pacific is the most rapidly growing market, led by China, and India. Incidence of gastrointestinal disease, and cancer, as well as increased healthcare infrastructure and government programs, fuel adoption of low-cost, advanced capsule endoscopes.

Market Segmentation

• By product type, the capsule endoscopes market is segmented into small bowel capsule and colon capsule. The small bowel capsule segment dominated the market in 2024.
• By application, the capsule endoscopes market is segmented into obscure gastrointestinal bleeding, Crohn's disease, tumor, celiac disease and others. The obscure gastrointestinal bleeding segment dominated the market in 2024.
• By end user, the market is segmented into hospitals, specialty clinics, diagnostic centers and others. The hospitals segment held the largest share of the market in 2024

Competitive Strategy & Development

Key Players: The Capsule Endoscopes market is populated by several key players, each contributing to its growth and innovation. Some prominent players are:

1. Medtronic
2. Olympus Corporation
3. CapsoVision, Inc.
4. BioCam
5. Shangxian Minimal Invasive Inc.
6. AnX Robotics
7. JINSHAN Science & Technology
8. RF Co., Ltd.

Trending Topics: Robotic-Assisted Endoscopy, Reusable Endoscopes, GI Endoscopy, Single-Use Capsule Endoscopes, Ultrasound Endoscope

Global Headlines

• CapsoVision announced FDA clearance for CapsoCam Plus® capsule endoscopy – In January 2025, CapsoVision announced that the FDA had cleared remote ingestion of its CapsoCam Plus® capsule endoscopy system. This allows patients to swallow the capsule from home under virtual supervision, expanding access to 360° panoramic small bowel imaging.
• AnX Robotica announced FDA 510(k) clearance for NaviCam ProScan – In January 2024, AnX Robotica announced that the FDA had granted clearance for its NaviCam ProScan™ software, the first AI-assisted reading tool for small bowel capsule endoscopy. Trained on over 150,000 images, it achieved 99.88% sensitivity in detecting abnormalities.

Conclusion

The capsule endoscopes market is set for substantial growth in the coming years. Rising prevalence of gastrointestinal disorders, including IBD, obscure GI bleeding, and colorectal cancer, combined with patient preference for minimally invasive, sedation-free diagnostics, is driving adoption. Innovations like AI-assisted image analysis, high-definition imaging, wireless systems, and portable capsules are expanding clinical applications while improving diagnostic accuracy, workflow efficiency, and patient safety. Challenges such as high device costs and limited trained professionals persist. Nevertheless, increasing product launches, collaborations between manufacturers and research institutes, and growing awareness of early detection benefits are accelerating market adoption. Capsule endoscopy is becoming essential for early diagnosis and improved patient outcomes worldwide.